
MetLife ownership: holders and insider trading
$102.65+0.77%Close 13 Nov 2026 · Market value $63.88B
As filed, its directors and officers own 0.4% of the shares (proxy statement, 31 Mar 2026); 1,437 institutional managers reported holding 77.0% at 30 Jun 2026. Over the last twelve months, insiders sold $21.04M of shares on the open market, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Company Board of Directors, but not in any Director's individual capacity | Holder | 105M | 16.2% | Proxy statement | 31 Mar 2026 |
|---|
| Board of Directors of MetLife, Inc., as an entity | Holder · active | 101M | 16% | Schedule 13D | 5 Nov 2026 |
|---|
| Vanguard | Institution | 71.4M | 11.31%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock | Institution | 51.8M | 8.21%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 41.5M | 6.36% | Schedule 13G | 31 Mar 2026 |
|---|
| Dodge & Cox | Institution | 33.6M | 5.3% | Schedule 13G | 30 Sep 2026 |
|---|
| State Street | Institution | 25.3M | 4.01%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 21.3M | 3.37%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 13.3M | 2.11%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 12.5M | 1.99%* | Form 13F | 30 Jun 2026 |
|---|
| Pzena Investment Management LLC | Institution | 11.1M | 1.76%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 8.5M | 1.34%* | Form 13F | 30 Jun 2026 |
|---|
| Dimensional Fund Advisors | Institution | 7.2M | 1.14%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 6.9M | 1.10%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 6.8M | 1.08%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 6.6M | 1.05%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 6.3M | 1.00%* | Form 13F | 30 Jun 2026 |
|---|
| Arrowstreet Capital, Limited Partnership | Institution | 5.8M | 0.92%* | Form 13F | 30 Jun 2026 |
|---|
| Clearbridge Investments, LLC | Institution | 5.6M | 0.89%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 5.4M | 0.85%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Khalaf Michel · President & CEO · Director | 10 Nov 2026 | Option exercise | +28.8K | $46.85 | $1.35M |
|---|
| Khalaf Michel · President & CEO · Director | 10 Nov 2026 | Option exercise | +34.6K | $45.50 | $1.57M |
|---|
| Khalaf Michel · President & CEO · Director | 10 Nov 2026 | Option exercise | +90.7K | $44.65 | $4.05M |
|---|
| Khalaf Michel · President & CEO · Director | 10 Nov 2026 | Option exercise | +94.6K | $47.58 | $4.50M |
|---|
| Khalaf Michel · President & CEO · Director | 10 Nov 2026 | Open-market sale | −187K | $102.97 | $19.30M |
|---|
| Mumenthaler Christian Stephane · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Hay Laura J · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Seitz Michelle · Director | 1 Oct 2026 | Grant or award | +544 | — | — |
|---|
| WEINBERGER MARK A · Director | 1 Oct 2026 | Grant or award | +544 | — | — |
|---|
| MCKENZIE DIANA · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Johnson Jeh C. · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Harris Carla A · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Glaser Daniel S · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| HUBBARD ROBERT GLENN · Director | 1 Oct 2026 | Grant or award | +941 | $94.35 | $88.78K |
|---|
| Kennard William E · Director | 1 Oct 2026 | Grant or award | +544 | $94.35 | $51.33K |
|---|
| Mumenthaler Christian Stephane · Director | 8 Sep 2026 | Grant or award | +21 | $95.50 | $2.01K |
|---|
| Hay Laura J · Director | 8 Sep 2026 | Grant or award | +39 | $95.50 | $3.72K |
|---|
| MCKENZIE DIANA · Director | 8 Sep 2026 | Grant or award | +157 | $95.50 | $14.99K |
|---|
| TADROS RAMY · President, U.S. Business | 8 Sep 2026 | Grant or award | +115 | $95.50 | $10.98K |
|---|
| Johnson Jeh C. · Director | 8 Sep 2026 | Grant or award | +59 | $95.50 | $5.63K |
|---|
| Harris Carla A · Director | 8 Sep 2026 | Grant or award | +42 | $95.50 | $4.01K |
|---|
| Glaser Daniel S · Director | 8 Sep 2026 | Grant or award | +10 | $95.50 | $955 |
|---|
| HUBBARD ROBERT GLENN · Director | 8 Sep 2026 | Grant or award | +618 | $95.50 | $59.02K |
|---|
| Kennard William E · Director | 8 Sep 2026 | Grant or award | +294 | $95.50 | $28.08K |
|---|
| PAPPAS BILL · EVP, Global Tech. & Ops. | 31 Aug 2026 | Shares withheld for tax | −4.0K | $95.17 | $383.5K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
MET in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.